Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Mesoblast Limited ( (AU:MSB) ) is now available.
JPMorgan Chase & Co. and its affiliates have become a substantial holder in Mesoblast Limited, acquiring a 5% voting power in the company as of July 15, 2025. This development indicates a significant investment and interest by JPMorgan in Mesoblast, potentially impacting the company’s market position and signaling confidence in its future prospects.
The most recent analyst rating on (AU:MSB) stock is a Buy with a A$3.40 price target. To see the full list of analyst forecasts on Mesoblast Limited stock, see the AU:MSB Stock Forecast page.
More about Mesoblast Limited
Average Trading Volume: 5,231,849
Technical Sentiment Signal: Hold
Current Market Cap: A$2.17B
See more insights into MSB stock on TipRanks’ Stock Analysis page.